Medical device recalls: September 2019
The FDA posted 31 medical device recall records in September 2019, from 8 recall events by 8 companies. 24 are Class I, the most serious category.
Each product in a recall gets its own record, so one recall event can cover several records. What recall classes mean.
Companies with the most recall events
- Allergan PLC · 1 event, 15 records, 15 Class I
- Teleflex Medical · 1 event, 8 records, 8 Class I
- Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · 1 event, 2 records
- Roche Diabetes Care, Inc. · 1 event, 2 records
- B. Braun Medical, Inc. · 1 event, 1 record, 1 Class I
- Exactech, Inc. · 1 event, 1 record
- GE Healthcare, LLC · 1 event, 1 record
- Helena Laboratories, Corp. · 1 event, 1 record
FDA root cause
- Unknown/Undetermined by firm · 16
- Process control · 8
- Other · 3
- Process change control · 2
- Nonconforming Material/Component · 1
- Device Design · 1
Class I recalls (24)
The most serious: a reasonable probability that using the device will cause serious health problems or death.
- Z-2489-2019 · B. Braun Medical, Inc. · posted Sep 23, 2019 · Terminated
Potential for the Infusion Pump Administration Set to leak and/or disconnect at the bonded joint between the tubing and Injection Site (Y-Site).
- Z-2451-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2452-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2453-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2454-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2455-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2456-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2457-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2458-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2459-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2460-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2461-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2462-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Komuro, Soft Touch, BIOCELL, INTRASHIEL, BioDIMENSIONAL breast implants, Styles KML, KMM, KLL, KLM ↗Class IZ-2463-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- RITZ PRINCESS, BIOCELL, INTRASHIEL, BioDIMENSIONAL Breast Implant, Styles RML, RMM, RFL, RFM ↗Class IZ-2464-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Z-2465-2019 · Allergan PLC · posted Sep 11, 2019 · Open, Classified
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
- Hudson RCI Sheridan LTS:Class IZ-2311-2019 · Teleflex Medical · posted Sep 9, 2019 · Terminated
Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical…
- Hudson RCI Sheridan/CF:Class IZ-2312-2019 · Teleflex Medical · posted Sep 9, 2019 · Terminated
Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical…
- Hudson RCI Sheridan EZ-ENDO:Class IZ-2313-2019 · Teleflex Medical · posted Sep 9, 2019 · Terminated
Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical…
- Z-2314-2019 · Teleflex Medical · posted Sep 9, 2019 · Terminated
Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical…
- Z-2315-2019 · Teleflex Medical · posted Sep 9, 2019 · Terminated
Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical…
- Hudson RCI Sheridan/HVT:Class IZ-2316-2019 · Teleflex Medical · posted Sep 9, 2019 · Terminated
Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical…
- Z-2317-2019 · Teleflex Medical · posted Sep 9, 2019 · Terminated
Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical…
- Sheridan/HVT Novaplus:Class IZ-2318-2019 · Teleflex Medical · posted Sep 9, 2019 · Terminated
Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical…
Class II recalls (7)
The device may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
- Z-2765-2019 · Roche Diabetes Care, Inc. · posted Sep 30, 2019 · Terminated
Meters may contain a damaged C29 capacitor resulting in issues with power allegation (short battery life or meter not turning on).
- Z-2766-2019 · Roche Diabetes Care, Inc. · posted Sep 30, 2019 · Terminated
Meters may contain a damaged C29 capacitor resulting in issues with power allegation (short battery life or meter not turning on).
- Z-2761-2019 · Helena Laboratories, Corp. · posted Sep 27, 2019 · Terminated
Some of the cards show occasional shorter clot times than the expected variation resulting in a potential false negative result on the screening assay.
- Proteus XR/a (SlOK : K993090)Class IIZ-2449-2019 · GE Healthcare, LLC · posted Sep 20, 2019 · Open, Classified
Intermittently not receiving an audible exposure indication upon completion of an exposure on the Proteus stationary radiographic system.
- Z-2499-2019 · Exactech, Inc. · posted Sep 10, 2019 · Terminated
The threaded mechanism of the Threaded Offset Cup Impactor may be gritty and difficult to turn potentially due to entrapped blast media.
- Z-2492-2019 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Sep 9, 2019 · Terminated
Medtronic is updating the Micra Instructions for Use (IFU) and the Micra Implant Procedure Tip Card to include specific information on the removal of the tether to release the Micra Pacemaker from the Micra Delivery System during implant.
- Z-2493-2019 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) · posted Sep 9, 2019 · Terminated
Medtronic is updating the Micra Instructions for Use (IFU) and the Micra Implant Procedure Tip Card to include specific information on the removal of the tether to release the Micra Pacemaker from the Micra Delivery System during implant.
Source: FDA Medical Device Recalls and FDA enforcement reports (recall class), via openFDA. Records are grouped by the date the FDA posted them. Methodology · Not medical advice.